U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07440901) titled 'Remodeling of MHC-related Immune Microenvironment in MIBC After Neoadjuvant Therapy' on Sept. 16, 2025.
Brief Summary: In this study, the relevant biomarkers for predicting the efficacy of neoadjuvant therapy in patients with MIBC were further explored. Meanwhile, the dynamic molecular monitoring of neoadjuvant therapy in MIBC patients and the treatment guidance based on the MHC tumor immune microenvironment were also explored to select the treatment plan based on relevant biomarkers for subsequent immunotherapy in MIBC patients.
Study Start Date: Feb. 01
Study Type: OBSERVATIONAL
Condition:
Muscle-invasive Bladder Cancer
Inter...